Advanced Oncotherapy plc (LON:AVO – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.77 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Price Performance
The stock’s fifty day moving average price is GBX 1.75 and its 200-day moving average price is GBX 1.77. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26. The firm has a market cap of £9.50 million, a PE ratio of -25.00 and a beta of 0.09.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Recommended Stories
- Five stocks we like better than Advanced Oncotherapy
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 4/22 – 4/26
- About the Markup Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- Options Trading – Understanding Strike Price
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
